Clinical pharmacology of nisoldipine, a new calcium antagonist
Krivonkin, K.I.; Belousov, I.B.
Kardiologiia 31(9): 100-105
1991
ISSN/ISBN: 0022-9040 PMID: 1753601 Document Number: 385371
Document emailed within 1 workday
Related Documents
Klein, H.H.; Nordbeck, H.; Kreuzer, H. 1983: Effect of the calcium antagonist nisoldipine on electrophysiologic parameters in the human Zeitschrift für Kardiologie 72(3): 180-182Loutzenhiser, R.; Epstein, M.; Horton, C.; Sonke, P. 1985: Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstriction Journal of Pharmacology and Experimental Therapeutics 232(2): 382-387
Kazda, S.; Garthoff, B.; Meyer, H.; Schlossmann, K.; Stoepel, K.; Towart, R.; Vater, W.; Wehinger, E. 1980: Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552) Arzneimittel-Forschung 30(12): 2144-2162
Sievert, H.; Friedmann, A.; Schräder, R.; Winkelmann, B.; Kaltenbach, M.; Kober, G. 1990: Effect of the calcium antagonist nisoldipine on coronary circulation and myocardial ischemia in temporary coronary occlusion Zeitschrift für Kardiologie 79(10): 683-688
Morita, T.; Fukuda, T.; Sukamoto, T.; Tajima, S.; Sato, I.; Ikeda, Y.; Kanazawa, T.; Hamada, Y.; Morimoto, Y.; Kitamura, H.; Kawakami, K.; Ito, K.; Nose, T. 1982: General pharmacology of KB-944, a new calcium antagonist Arzneimittel-Forschung 32(9): 1060-1068
Lee, J.Y.; Rozek, L.F.; Sanner, J.H.; Radzialowski, F.M. 1983: Cardiovascular pharmacology of a calcium antagonist antihypertensive agent, SC-30552 Methods and Findings in Experimental and Clinical Pharmacology 5(4): 235-249
Upward, J.W.; Arnold, B.D.; Link, C.; Pierce, D.M.; Allen, A.; Tasker, T.C. 1990: The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist European Journal of Cancer 26(Suppl 1): S12-S15
Millar, J.A.; Bramley, P.M. 1984: Clinical pharmacology of calcium antagonists Methods and Findings in Experimental and Clinical Pharmacology 6(4): 205-211
Liu, W.H.; Fu, S.X.; Li, Y.S. 1992: Antihypertensive effects of m-nisoldipine and nisoldipine on conscious renal hypertensive rats and dogs Zhongguo Yao Li Xue Bao 13(1): 31-35
Sinaiko, A.R. 1994: Clinical pharmacology of converting enzyme inhibitors, calcium channel blockers and diuretics Journal of Human Hypertension 8(5): 389-394
An, R.H.; He, R.R. 1990: Electrophysiological effects of m-nisoldipine and nisoldipine on papillary muscles of guinea pig Zhongguo Yao Li Xue Bao 11(4): 310-314
Ahr, H.J.; Krause, H.P.; Suwelack, D.; Weber, H. 1988: Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C]nisoldipine to rats and dogs Arzneimittel-Forschung 38(8): 1099-1104
Matsumoto, J.; Minami, T.; Sato, T.; Onodera, T. 1992: A clinical trial of arterial infusion chemotherapy combined with calcium antagonist for liver metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1553-1556
Escudero, J.; Hernandez, H. 1991: Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension International Journal of Clinical Pharmacology Research 11(5): 243-246
Li, F.F.; Fu, S.X.; Li, Y.S. 1992: Effects of m-nisoldipine and nisoldipine on isolated uterine muscle Zhongguo Yao Li Xue Bao 13(1): 59-62
Scherling, D.; Karl, W.; Ahr, G.; Ahr, H.J.; Wehinger, E. 1988: Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man Arzneimittel-Forschung 38(8): 1105-1110
Eigenmann, R.; Blaber, L.; Nakamura, K.; Thorens, S.; Haeusler, G. 1981: Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies Arzneimittel-Forschung 31(9): 1393-1401
Matsuda, S. 1991: Protective effects of calcium antagonist (nitrendipine) on calcium ionophore A23187-induced liver cell injury Bulletin of Tokyo Medical and Dental University 38(3): 35-44
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Pimenov, L.T.; Ezhov, A.V.; Churshin, A.D.; Dudarev, M.V. 1996: The clinical, hemodynamic and hormonal-metabolic effects of the calcium-antagonist treatment of middle-aged and elderly patients with IHD at the polyclinic stage of rehabilitation Terapevticheskii Arkhiv 68(1): 42-45